Jan 17, 2024, 19:34
Yüksel Ürün: The U.S. FDA has approved pembrolizumab in combination with chemoradiotherapy for FIGO 2014 Stage III-IVA cervical cancer
Yüksel Ürün, Professor at the Department of Medical Oncology at the Ankara University School of Medicine, shared on X/Twitter:
“The U.S. FDA has approved pembrolizumab in combination with chemoradiotherapy for FIGO 2014 Stage III-IVA cervical cancer. This decision follows the PFS benefit shown in the KEYNOTE-A18 trial.
OS data were not mature!
Reminding: the best way to treat cervical cancer is PREVENTION!!!!”
View additional information.
Source: Yüksel Ürün/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 22:40
Dec 21, 2024, 22:37
Dec 21, 2024, 22:26
Dec 21, 2024, 19:39
Dec 21, 2024, 19:21
Dec 21, 2024, 19:19